{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:23:52Z","timestamp":1769160232393,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,2,26]],"date-time":"2008-02-26T00:00:00Z","timestamp":1203984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s00403-008-0837-2","type":"journal-article","created":{"date-parts":[[2008,2,25]],"date-time":"2008-02-25T09:22:20Z","timestamp":1203931340000},"page":"235-242","source":"Crossref","is-referenced-by-count":9,"title":["Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11"],"prefix":"10.1007","volume":"300","author":[{"given":"Yan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Jia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,26]]},"reference":[{"key":"837_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.192.1.63","volume":"192","author":"V Appay","year":"2000","unstructured":"Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL (2000) HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 192:63","journal-title":"J Exp Med"},{"key":"837_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0952-7915(99)80035-1","volume":"11","author":"S Buus","year":"1999","unstructured":"Buus S (1999) Description and prediction of peptide-MHC binding: the\u2019human MHC project\u2019. Curr Opin Immunol 11:209\u2013213","journal-title":"Curr Opin Immunol"},{"key":"837_CR3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1172\/JCI200112346","volume":"108","author":"WF Cheng","year":"2001","unstructured":"Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Ling M, Wu TC (2001) Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 108:669\u2013678","journal-title":"J Clin Invest"},{"key":"837_CR4","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1128\/JVI.63.11.4898-4903.1989","volume":"63","author":"EM Villiers de","year":"1989","unstructured":"de Villiers EM (1989) Heterogeneity of the human papillomavirus group. J Virol 63:4898\u20134903","journal-title":"J Virol"},{"key":"837_CR5","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/eji.1830230929","volume":"23","author":"MC Feltkamp","year":"1993","unstructured":"Feltkamp MC, Smits HL, Vierboom MP, Minnaar RP, de Jongh BM, Drijfhout JW, ter Schegget J, Melief CJ, Kast WM (1993) Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 23:2242\u20132249","journal-title":"Eur J Immunol"},{"key":"837_CR6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2249.1999.00813.x","volume":"115","author":"GJ Fernando","year":"1999","unstructured":"Fernando GJ, Murray B, Zhou J, Frazer IH (1999) Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16. Clin Exp Immunol 115:397\u2013403","journal-title":"Clin Exp Immunol"},{"key":"837_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-1759(01)00477-X","volume":"258","author":"JF Fonteneau","year":"2001","unstructured":"Fonteneau JF, Larsson M, Somersan S, Sanders C, Munz C, Kwok WW, Bhardwaj N, Jotereau F (2001) Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cells. J Immunol Methods 258:111\u2013126","journal-title":"J Immunol Methods"},{"key":"837_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-065X.1999.tb01288.x","volume":"168","author":"IH Frazer","year":"1999","unstructured":"Frazer IH, Thomas R, Zhou J, Leggatt GR, Dunn L, McMillan N, Tindle RW, Filgueira L, Manders P, Barnard P, Sharkey M (1999) Potential strategies utilised by papillomavirus to evade host immunity. Immunol Rev 168:131\u2013142","journal-title":"Immunol Rev"},{"key":"837_CR9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.187.10.1647-b","volume":"187","author":"A Gallimore","year":"1998","unstructured":"Gallimore A, Dumrese T, Hengartner H, Zinkernage RM, Rammensee HG (1998) Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med 187:1647\u20131657","journal-title":"J Exp Med"},{"key":"837_CR10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ijc.10084","volume":"97","author":"SL Giannini","year":"2002","unstructured":"Giannini SL, Hubert P, Doyen J, Boniver J, Delvenne P (2002) Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Int J Cancer 97:654\u2013659","journal-title":"Int J Cancer"},{"key":"837_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1999.tb01351.x","volume":"172","author":"GJ Hammerling","year":"1999","unstructured":"Hammerling GJ, Vogt AB, Kropshofer H (1999) Antigen processing and presentation\u2014towards the millennium. Immunol Rev 172:5\u201311","journal-title":"Immunol Rev"},{"key":"837_CR12","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1158\/1078-0432.CCR-05-2791","volume":"12","author":"N Hirano","year":"2006","unstructured":"Hirano N, Butler MO, Xia Z, Berezovskaya A, Murray AP, Ans\u00e9n S, Nadler LM (2006) Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responses. Clin Cancer Res 12:2967\u20132975","journal-title":"Clin Cancer Res"},{"key":"837_CR13","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/ijc.21565","volume":"118","author":"TK Hoffmann","year":"2006","unstructured":"Hoffmann TK, Arsov C, Schirlau K, Bas M, Friebe-Hoffmann U, Klussmann JP, Scheckenbach K, Balz V, Bier H, Whiteside TL (2006) T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx. Int J Cancer 118:1984\u20131991","journal-title":"Int J Cancer"},{"key":"837_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1346-8138.2000.tb02126.x","volume":"27","author":"T Ishiji","year":"2000","unstructured":"Ishiji T (2000) Molecular mechanism of carcinogenesis by human papillomavirus-16. J Dermatol 27:73\u201386","journal-title":"J Dermatol"},{"key":"837_CR15","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.4049\/jimmunol.152.8.3904","volume":"152","author":"W Kast","year":"1994","unstructured":"Kast W, Brandt R, Sidney J, Drijfhout J, Kubo RT, Grey HM, Melief C, Sette A (1994) Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type-16 E6 and E7 proteins. J Immunol 152:3904\u20133912","journal-title":"J Immunol"},{"key":"837_CR16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM200104123441503","volume":"344","author":"J Mork","year":"2001","unstructured":"Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125\u20131131","journal-title":"N Engl J Med"},{"key":"837_CR17","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1002\/j.1460-2075.1989.tb08594.x","volume":"8","author":"K M\u00fcnger","year":"1989","unstructured":"M\u00fcnger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8:4099\u20134105","journal-title":"EMBO J"},{"key":"837_CR18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1128\/CDLI.11.5.889-896.2004","volume":"11","author":"M Nakagawa","year":"2004","unstructured":"Nakagawa M, Kim KH, Moscicki AB (2004) Different methods of identifying new antigenic epitopes of human papillomavirus type 16 E6 and E7 proteins. Clin Diagn Lab Immunol 11:889\u2013896","journal-title":"Clin Diagn Lab Immunol"},{"key":"837_CR19","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/CDLI.12.8.1003-1005.2005","volume":"12","author":"M Nakagawa","year":"2005","unstructured":"Nakagawa M, Kim KH, Moscicki AB (2005) Patterns of CD8 T-cell epitopes within the human papillomavirus type 16 (HPV 16) E6 protein among young women whose HPV 16 infection has become undetectable. Clin Diagn Lab Immunol 12:1003\u20131005","journal-title":"Clin Diagn Lab Immunol"},{"key":"837_CR20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/315706","volume":"182","author":"M Nakagawa","year":"2000","unstructured":"Nakagawa M, Stites DP, Patel S, Farhat S, Scott M, Hills NK, Palefsky JM, Moscicki AB (2000) Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens. J Infect Dis 182:595\u2013598","journal-title":"J Infect Dis"},{"key":"837_CR21","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.vaccine.2005.12.061","volume":"24","author":"P Ohlschlager","year":"2006","unstructured":"Ohlschlager P, Pes M, Osen W, Durst M, Schneider A, Gissmann L, Kaufmann AM (2006) An improved rearranged human papillomavirus type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response. Vaccine 24:2880\u20132893","journal-title":"Vaccine"},{"key":"837_CR22","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1016\/S0264-410X(01)00154-2","volume":"19","author":"W Osen","year":"2001","unstructured":"Osen W, Peiler T, Ohlschlager P, Caldeira S, Faath S, Michel N, Muller M, Tommasino M, Jochmus I, Gissmann L (2001) A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity. Vaccine 19:4276\u20134286","journal-title":"Vaccine"},{"key":"837_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","volume":"152","author":"KC Parker","year":"1994","unstructured":"Parker KC, Bednarek MA, Coligan JE (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152:163\u2013175","journal-title":"J Immunol"},{"key":"837_CR24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2567.2006.02465.x","volume":"119","author":"JA Passmore","year":"2006","unstructured":"Passmore JA, Milner M, Denny L, Sampson C, Marais DJ, Allan B, Gumbi PP, Hitzeroth II, Rybicki EP, Williamson AL (2006) Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia. Immunology 119:507\u2013514","journal-title":"Immunology"},{"key":"837_CR25","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.78.16.8468-8476.2004","volume":"78","author":"S Peng","year":"2004","unstructured":"Peng S, Ji H, Trimble C, He L, Tsai YC, Yeatermeyer J, Boyd DA, Hung CF, Wu TC (2004) Development of a DNA vaccine targeting human papsillomavirus type 16 oncoprotein E6. J Virol 78:8468\u20138476","journal-title":"J Virol"},{"key":"837_CR26","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.4049\/jimmunol.154.11.5934","volume":"154","author":"ME Ressing","year":"1995","unstructured":"Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM (1995) Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A *0201 binding peptides. J Immunol 154:5934\u20135943","journal-title":"J Immunol"},{"key":"837_CR27","first-page":"929","volume":"74","author":"J Ruppert","year":"1993","unstructured":"Ruppert J, Sidney J, Esteban C, Kubo RT, Grey HM, Sette A (1993) Prominent role of secondary anchor residues in peptide binding to HLA-A2.1. Mol Cell 74:929\u2013938","journal-title":"Mol Cell"},{"key":"837_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/intimm\/6.2.289","volume":"6","author":"E Sadovnikova","year":"1994","unstructured":"Sadovnikova E, Zhu X, Collins SM, Zhou J, Vousden K, Crawford L, Beverley P, Stauss HJ (1994) Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein. Int Immunol 6:289\u2013296","journal-title":"Int Immunol"},{"key":"837_CR29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2004.11.005","volume":"114","author":"KB Scholten","year":"2005","unstructured":"Scholten KB, Schreurs MW, Ruizendaal JJ, Kueter EW, Kramer D, Veenbergen S, Meijer CJ, Hooijberg E (2005) Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer. Clin Immunol 114:119\u2013129","journal-title":"Clin Immunol"},{"key":"837_CR30","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.4049\/jimmunol.171.6.2912","volume":"171","author":"MW Schreurs","year":"2003","unstructured":"Schreurs MW, Scholten KB, Kueter EW, Ruizendaal JJ, Meijer CJ, Hooijberg E (2003) In Vitro Generation and Life Span Extension of Human Papillomavirus Type 16-Specific, Healthy Donor-Derived CTL Clones. J Immunol 171:2912\u20132921","journal-title":"J Immunol"},{"key":"837_CR31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/intimm\/dxh197","volume":"17","author":"KL Smith","year":"2005","unstructured":"Smith KL, Tristram A, Gallagher KM, Fiander AN, Man S (2005) Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18. Int Immunol 17:167\u2013176","journal-title":"Int Immunol"},{"key":"837_CR32","first-page":"222","volume":"81","author":"I Tarpey","year":"1994","unstructured":"Tarpey I, Stacey S, Hickling J, Birley HD, Renton A, McIndoe A, Davies DH (1994) Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif. Immunology 81:222\u2013227","journal-title":"Immunology"},{"key":"837_CR33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/intimm\/dxl089","volume":"18","author":"G Telusma","year":"2006","unstructured":"Telusma G, Datta S, Mihajlov I, Ma W, Li J, Yang H, Newman W, Messmer BT, Minev B, Schmidt-Wolf IG, Tracey KJ, Chiorazzi N, Messmer D (2006) Dendritic cell activating peptides induce distinct cytokine profiles. Int Immunol 18:563\u2013573","journal-title":"Int Immunol"},{"key":"837_CR34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc700","volume":"2","author":"RW Tindle","year":"2002","unstructured":"Tindle RW (2002) Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer 2:59\u201365","journal-title":"Nat Rev Cancer"},{"key":"837_CR35","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.4049\/jimmunol.160.9.4449","volume":"160","author":"RE Toes","year":"1998","unstructured":"Toes RE, van der Voort EI, Schoenberger SP, Drijfhout JW, van Bloois L, Storm G, Kast WM, Offringa R, Melief CJ (1998) Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol 160:4449\u20134456","journal-title":"J Immunol"},{"key":"837_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1615\/CritRevImmunol.v18.i1-2.80","volume":"18","author":"V Tsai","year":"1998","unstructured":"Tsai V, Kawashima I, Keogh E, Daly K, Sette A, Celis E (1998) In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells. Crit Rev Immunol 18:65\u201375","journal-title":"Crit Rev Immunol"},{"key":"837_CR37","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/eji.1830271033","volume":"27","author":"T Tuting","year":"1997","unstructured":"Tuting T, DeLeo AB, Lotze MT, Storkus WJ (1997) Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or \u201cself\u201d antigens induce antitumor immunity in vivo. Eur J Immunol 27:2702\u20132707","journal-title":"Eur J Immunol"},{"key":"837_CR38","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1016\/j.vaccine.2005.04.049","volume":"23","author":"A Vambutas","year":"2005","unstructured":"Vambutas A, DeVoti J, Nouri M, Drijfhout JW, Lipford GB, Bonagura VR, van der Burg SH, Melief CJ (2005) Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model. Vaccine 23:5271\u20135280","journal-title":"Vaccine"},{"key":"837_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(02)00105-6","volume":"123","author":"P Wang","year":"2002","unstructured":"Wang P, Wang Q, Sims PF, Hyde JE (2002) Rapid positive selection of stable integrants following transfection of Plasmodium falciparum. Mol Biochem Parasitol 123:1\u201310","journal-title":"Mol Biochem Parasitol"},{"key":"837_CR40","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2003-08-2828","volume":"103","author":"T Wan","year":"2004","unstructured":"Wan T, Zhou XY, Chen GY, An HZ, Chen TY, Zhang WP, Liu SX, Jiang YM, Yang F, Wu YF, Cao XT (2004) Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant. Blood 103:1747\u20131754","journal-title":"Blood"},{"key":"837_CR41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0168-1702(98)00008-2","volume":"54","author":"H Yoon","year":"1998","unstructured":"Yoon H, Chung MK, Min SS, Lee HG, Yoo WD, Chung KT, Jung NP, Park SN (1998) Synthetic peptides of human papillomavirus type 18 E6 harboring HLA-A2.1 motif can induce peptide-specific cytotoxic T-cells from peripheral blood mononuclear cells of healthy donors. Virus Res 54:23\u201329","journal-title":"Virus Res"},{"key":"837_CR42","first-page":"365","volume":"60","author":"SJ Youde","year":"2000","unstructured":"Youde SJ, Dunbar PR, Evans EM, Fiander AN, Borysiewicz LK, Cerundolo V, Man S (2000) Use of Fluorogenic Histocompatibility Leukocyte Antigen-A*0201\/HPV 16 E7 Peptide Complexes to Isolate Rare Human Cytotoxic T-Lymphocyte- recognizing Endogenous Human Papillomavirus Antigens. Cancer Res 60:365\u2013371","journal-title":"Cancer Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0837-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-008-0837-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0837-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T16:48:03Z","timestamp":1684255683000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-008-0837-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,26]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1007\/s00403-008-0837-2","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,26]]}}}